ENTITY
Access Bio Inc

Access Bio Inc (950130 KS)

19
Analysis
Health CareSouth Korea
Access Bio Inc. develops, manufactures, and markets in-vitro diagnostic (IVD) tests. The Company develops rapid diagnostic test (RDT) for Malaria and Pregnancy.
more
bullishWonik QnC Corp
05 Aug 2021 07:44

KOSDAQ150 Index Rebalance Preview: Inclusions Outperforming as Short Sell Ban Helps

Halfway through the review period, we see 15 potential changes to the index. The potential inclusions are outperforming the exclusions as short...

Logo
280 Views
Share
bullishWonik QnC Corp
07 Jun 2021 13:33

KOSDAQ150 Index Rebalance Preview: Lots of Changes Early in the Review Period

A month into the review period for the KOSDAQ150 December rebalance, we can already see 12 potential changes. The potential inclusions should...

Logo
233 Views
Share
30 Nov 2020 19:48

Biden COVID-19 Response Plan: Its Largest Near-Term Opportunity Is In Testing Stocks

COVID-19 testing stocks represent the largest, most tangible, and nearest-term investment opportunity inherent in Biden's recently-announced COVID...

Logo
222 Views
Share
11 Mar 2020 00:58

Full Details & Current Designation List - Short-Selling Restriction Rule Change in Korea

It is now official that we have a new short-selling restriction rule, which is effective as of March 11. For the existing regulations, we now have...

Logo
351 Views
Share
20 Feb 2017 06:10

ASTA IPO Part 2 - Growth Potential & Appropriate Valuation Level

* In Part 2 (as below), I summarized the company's growth potential and appropriate valuation level.Who is ASTA again? The company is a biomass...

Logo
539 Views
Share
x